MedTrace Logo

Pulmonary Disease Requiring Ambulatory Oxygen Therapy -Resilience and Quality of Life

NCT04554225 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2023-10-26

No results posted yet for this study

Summary

Dyspnea is common symptom in pulmonary diseases, like chronic obstructive pulmonary disease (COPD) or other pulmonary disease. Ambulatory oxygen therapy is often prescribed to these patients. In these patients resilience, health related quality of life, life satisfaction are measured and the effect and patient satisfaction to ambulatory oxygen therapy are studied.

Conditions

  • Pulmonary Disease

Interventions

DRUG

Oxygen gas

Oxygen administered to a patient using ambulatory oxygen

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • Tampere University Hospital

    collaborator OTHER

  • Kuopio University Hospital

    lead OTHER

Principal Investigators

  • Merja Kokki, V · Kuopio University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2022-07-29
Completion
2023-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04554225 on ClinicalTrials.gov